Ilomedin® 20 μg/1 ml, Konzentrat zur Herstellung einer Infusionslösung clinical trials

A phase I/IIa, prospective, mono-center, randomized, open labeled, controlled study to assess the safety and efficacy of applying Iloprost locally in the fracture site to promote bone healing in patients with proximal humeral fracture - ILOBONE

This study is looking at a new way to help broken upper arm bones heal better. Researchers are testing a medicine called Iloprost applied directly to the fracture site to see if it's safe and helps the bone repair itself.